SlideShare a Scribd company logo
1 of 43
Hypertensive Disorders in Pregnancy
By
Francis Kamwendo
@
Nkhota-kota
Adapted from Obstetrics Simplified
by Diaa M. EI-Mowafi
Classification
1. PRE-EXISTING (CHRONIC) HYPERTENSION
2. PRE-ECLAMPSIA
1. Differential Diagnosis
2. Complications
3. Treatment
4. ECLAMPSIA
Pre-existing (chronic) hypertension:
– Hypertension is present before pregnancy,
detected in early pregnancy (before 20 weeks in
absence of vesicular mole) and postpartum.
– Examples:
• essential hypertension,
• secondary to chronic renal disorders e.g. pyelonephritis
and renal artery stenosis,
• coarctation of the aorta, systemic lupus erythematosus
and pheochromocytoma.
PRE-EXISTING (CHRONIC) HYPERTENSION
Causes
• Essential hypertension: of unknown aetiology.
• Secondary to chronic renal disorder: e.g.
– Glomerulonephritis.
– Hydronephrosis.
– Pyelonephritis.
– Renal artery stenosis.
• Secondary to cardiovascular disease: e.g.
– Coarctation of the aorta.
– Polyartheritis nodosa.
– Systemic lupus erythematosus.
PRE-EXISTING (CHRONIC)
HYPERTENSION
• Causes
• Secondary to endocrine disorders: e.g.
– Primary aldosteronism.
– Phaeochromocytoma.
– Adrenocortical tumours.
– Diabetes mellitus.
Effect of Pregnancy on Chronic
Hypertension
• Blood pressure falls by the second trimester in
most of cases, but rises during the third
trimester to a level some what above that in
early pregnancy.
• Deterioration of the underlying disease.
Effect of Chronic Hypertension on Pregnancy
Maternal:
• superimposed pre-
eclampsia/ eclampsia in 15-
20% of cases
Foetal:
– Intrauterine growth
retardation.
– Intrauterine foetal
death.
Treatment
• General and medical treatment
• As pre-eclampsia regarding the following:
• Rest
• Antihypertensives
• Observation
Pregnancy-induced hypertension
(PIH):
– Transient hypertension:
• Late onset hypertension, without proteinuria or
pathologic oedema
– Pre-eclampsia:
• Hypertension with proteinuria and / or oedema after
20 weeks of pregnancy, but may be earlier in vesicular
mole.
– Eclampsia:
• Pre-eclampsia + convulsions.
Superimposed pre-eclampsia or
eclampsia:
– Development of pre-eclampsia or eclampsia in
pre-existing hypertension detected by a further
increase of 30 mmHg or more in systolic blood
pressure or 15 mmHg or more in diastolic blood
pressure.
PRE-ECLAMPSIA
• Incidence: 5-10%.
• Aetiology:
Although eclampsia had been described
since 200 years, no definite aetiology is
found for PIH and it is still a disease of
theories.
Predisposing factors
• Primigravidae more than multigravidae.
• Pre-existing hypertension.
• Previous pre-eclampsia.
• Family history of pre-eclampsia.
• Hyperplacentosis i.e. excessive chorionic tissue as
in hydatidiform mole, multiple pregnancy,
uncontrolled diabetes mellitus and foetal
haemolytic diseases.
• Obesity.
•
Theories
• The uteroplacental bed
• Immunological factor
• Genetic factor
• Renin- angiotensin system
• Atrial natriuretic peptide (ANP)
• Prostaglandins
• Neutrophils
Pathological Changes
• Vasospasm
• Coagulation status
• Sodium and water retention
Diagnosis
• Signs
• Symptoms
Signs
• Hypertension:
• Proteinuria (albuminuria):
• Oedema:
Hypertension
• Blood pressure of 140/90 mmHg or more or
an increase of 30 mmHg in systolic and/or 15
mmHg in diastolic blood pressure over the
pre- or early pregnancy level.
How to measure the blood pressure in
pregnancy 1
• The patient should rest for at least 30 min. after
arriving to the clinic.
• Remove any tight clothing from the right arm.
• The patient lies comfortably on the left side that her
back makes an angle of about 30o with the bed. The
right arm is supported to be with the
sphygmomanometer at the same level with the
patient’s sternum i.e. her heart. Each cm above or
below the level of the heart induces a difference of
0.7mmHg in blood pressure reading. She should lie
undisturbed in this position for 2-3 min. before blood
pressure is measured.
How to measure the blood pressure in
pregnancy 2
• The cuff should be applied to the right upper arm with
the connecting tubes pointing downwards, the centre
of the rubber bag in the cuff is directly over the
brachial artery leaving ante-cubital fossa free.
• Apply cuff firmly but not tightly around the arm.
• Feel the brachial artery and apply the stethoscope
directly over it without undue pressure.
• Pump up cuff rapidly to 20-30 mmHg above the point
at which the pulse sound disappears, and take blood
pressure reading without delay.
How to measure the blood pressure in
pregnancy 3
• Let air out slowly so that mercury falls steadily by 2-3
mm/sec.
• Blood pressure measurement phases (Korotkoff):
– Korotkoff I¾ Appearance of the sound¾ systolic reading.
– Korotkoff II¾ Accentuation of the sound.
– Korotkoff III ¾ Sound becomes harsh.
– Korotkoff IV¾ Sound becomes muffled¾ diastolic reading.
– Korotkoff V¾ Disappearance of the sound.
• Korotkoff I and IV is the reading for systolic and diastolic
blood pressure respectively. If you wait the disappearance
of the sound to take the diastolic reading (as in non-
pregnant state) you may reach down to zero because of the
hyperdynamic circulation during pregnancy.
How to measure the blood pressure in
pregnancy 4
• Use the right arm for measuring because it is
more convenient to the physician, but if the
reading is 10 mmHg or more higher in the left
arm use it in the future readings.
• The blood pressure should be measured in
two occasions at least 6 hours apart.
Proteinuria (albuminuria)
• It is urinary protein greater than 0.3gm/L in 24
hours collection or greater than 1gm/L in two
random samples obtained at least 6 hours
apart.
• It indicates glomerular damage and almost
always occurs after hypertension.
• Proteinuria is usually in the range of 1-3 gm
daily, of which 50-60% is albumin but in
severe cases it may exceed 15gm.
Oedema
• It is weight gain of more than 1 kg in any one
week or 2.25 kg in any one month.
• Clinical oedema is present in about two-thirds
of patients with PIH. However, two-thirds of
pregnant women with clinical oedema do not
develop hypertension.
Symptoms
These are usually manifestations of severe pre-eclampsia.
• Headache: usually frontal but may be occipital. It is due
to cerebral oedema and hypertension.
• Visual disturbances: blurring of vision, flashes of light
or blindness.
• Epigastric or right upper quadrant pain: due to
enlargement and subcapsular hemorrhage of the liver.
• Nausea and vomiting: due to congestion of gastric
mucosa and/ or cerebral oedema.
• Oliguria or anuria: due to kidney pathology.
Investigations
• Complete urine examination: for proteinuria, pus cells,
RBCs, casts, specific gravity, culture and sensitivity.
• Kidney function tests: serum uric acid > 6 mg % is abnormal
during pregnancy. It is more specific for pre-eclampsia than
creatinine.
• Coagulation status: Platelet count, fibrinogen and FDP as
DIC may develop.
• Eye fundus examination.
• Tests for foetal well being: as
– ultrasound,
– daily foetal movement count,
– non-stress test,
– oxytocin challenge test (if needed).
N.B.
• Imminent eclampsia: It is a state in which the patient is
about to develop eclampsia. Usually there are:
– blood pressure much higher than 160 /110 mmHg,
– heavy proteinuria (+++or ++++),
– hyperreflexia,
– severe continuous headache,
– blurring of vision,
– epigastric pain.
• Fulminating pre-eclampsia: a rapidly deteriorating pre-
eclampsia to be imminent eclampsia
Pre-eclampsia Pre-existing
(chronic)
Hypertension
Parity usually
primigravida
usually
multigravida.
Past History of pre-eclampsia
may be present
of hypertension in
between
pregnancies.
Hypertension after the 20th week
of pregnancy
(except in vesicular
mole) and
disappears within 6
weeks postpartum
before pregnancy,
during the first 20
weeks and persists
after 6 weeks
postpartum.
Proteinuria If present, it
develops after
hypertension
If present, it
develops before
hypertension due
to underlying renal
disease.
Pre-eclampsia Pre-existing (chronic)
Hypertension
Hyperreflexia may be present. absent.
Fundus Examination Normal or retinal vessels
spasm, oedema, exudate
and papilloedema (oedema
of the optic disc).
Sclerotic changes.
Serum Uric Acid Its increase is not
proportionate to serum
creatinine
Its increase is propotionate
to serum creatinine
Differential Diagnosis
• Other causes of hypertension
• Other Causes of proteinuria
• Other causes of oedema
Other Causes of proteinuria
• Contamination of urine by vaginal discharge this is
excluded by examination of a midstream sample after
cleansing the introitus with sterile water or saline or by
using a catheter.
• Urinary infection: excluded by microscopic examination
and culture of urine.
• Congestive heart failure and severe anaemia due to
hypoxia of the kidney.
• Orthostatic proteinuria: Proteinuria is detected at the
end of the day while it is absent in the morning. This is
due to pressure of the lumbar spines on the left renal
vein during standing
Other causes of oedema
• General causes: cardiac, hepatic, renal or
nutritional oedema.
• Local causes: as inflammatory or deep vein
thrombosis (usually unilateral).
• Pressure of the gravid uterus on the pelvic
veins may produce ankle oedema.
Complications
Maternal:
– Convulsions and coma
(eclampsia).
– Cerebral haemorrhage.
– Renal failure.
– Heart failure.
– Liver failure.
– Disseminated intravascular
coagulation.
– Abruptio placentae.
– Residual chronic hypertension
in about 1/3 of cases.
– Recurrent pre-eclampsia in
next pregnancies.
Foetal:
– Intrauterine growth
retardation (IUGR).
– Intrauterine foetal death.
– Prematurity and its
complications.
Treatment
• Prophylactic
• Curative
Prophylactic
• Proper antenatal care:
– To detect the high risk patients who may develop PIH through
the screening tests.
– Early detection of cases who have already developed PIH and
examine them more frequently.
• Low dose aspirin:
– It inhibits thromboxane production from the platelets and the
AII binding sites on platelets.
– A low dose (60 mg daily) selectively inhibits thromboxane due to
higher concentration of such a low dose in the portal circulation
than systemic affecting the platelets when they pass through
the portal circulation. The Prostacyclin production from the
systemic vessels will not be affected.
Curative
• Delivery of the foetus and placenta is the only
real treatment of pre-eclampsia. As the
conditions are not always suitable for this, the
treatment aims to prevent or minimize the
maternal and foetal complications (see
before) till reasonable maturation of the
foetus.
General measures:
Observation:
Maternal:
• blood pressure twice daily.
• urine volume and
proteinuria daily,
• oedema daily,
• body weight twice weekly,
• fundus oculi once weekly,
• blood picture including
platelet count, liver and
renal functions particularly
serum uric acid on
admission.
Foetal:
• daily foetal movement
count,
• serial sonography,
• non-stress and stress test if
needed.
Medical treatment
• Antihypertensives:
– decrease the maternal cerebral and cardiovascular complications but do not affect the foetal
outcome.
– Alpha-methyl-dopa (Aldomet):
• It reduces the central sympathetic drive.
• Dose: 250-500 mg every 6-8 hours up to a maximum dose of 4 gm/day. Its effect appears after 48
hours.
• A loading single dose of 2 gm may act within 1-2 hours.
• Side effects: headache, athenia and nightmares.
– Hydralazine (Apresoline):
• It is a vasodilator, increases renal and uteroplacental blood flow.
• Dose: 20 mg slowly IV initially followed by 5mg every 20 min. until diastolic blood pressure is 100-110
mmHg. This regimen is used for severe and acute hypertension. Oral hydralazine can be used in the
chronic situation as a second line treatment in a dose of 25-75 mg/ 6 hours.
• Side effects: tachycardia, headache, flushing, nausea and vomiting.
– Calcium channel blockers (Nifedipine):
• It is a vasodilator acting by blocking the Ca influx into smooth muscle cells.
• It can be given sublingually (acts within 10 minutes) or orally (acts within 30 minutes) in a dose of 10-
20 mg 2-3 times daily.
• The higher the starting blood pressure the greater is the hypotensive effect.
• Side effects: headache and flushing.
Obstetric measures
• Timing of delivery
• Method of delivery
• Intrapartum care
• Postpartum care
Timing of delivery: Severe pre-eclampsia is usually treated
conservatively till the end of the 36th week to ensure reasonable
maturation of the foetus. Indications of termination before 36th
week include:
Foetal: deteriorating placental
function as judged by:
– intrauterine growth
retardation,
– oligohydramnios,
– reduced foetal
movements,
– abnormal foetal heart
patterns, or
– failing biochemical results.
Maternal: deteriorating maternal
condition as judged by:
– blood pressure is sustained
or exceeds 180/110
mmHg,
– urine proteinuria > 5
gm/24 hours,
– oliguria,
– evidence of DIC, or
– imminent or already
developed eclampsia.
Method of delivery:
– Vaginal delivery may be commenced in vertex
presentation by:
• amniotomy + oxytocin if the cervix is favourable.
• prostaglandin vaginal tablet (PGE2) if the cervix is not
favourable.
– Caesarean section is indicated in:
• Foetal distress.
• Late deceleration occurs with oxytocin challenge test.
• Failure of induction of labour.
• Other indications as contracted pelvis, and
malpresentations.
Intrapartum care:
– Close monitoring of the foetus is indicated.
– Proper analgesia to the mother.
– Anti-Hypertensives may be given if needed.
– 2nd stage of labour may be shortened by forceps.
Postpartum care:
– Methergin (Ergometrine) is better avoided as it
may increase the blood pressure.
– Continue observation of the mother for 48 hours.
– Anti- hypertensive drugs are continued in a
decreasing dose for 48 hours.
Thank you

More Related Content

Similar to m1_f._kamwendo_-_hypertensive_disorders_in_pregnancy.ppt.pptx

Hypertensive-Disorders-with-Pregnancy.ppt
Hypertensive-Disorders-with-Pregnancy.pptHypertensive-Disorders-with-Pregnancy.ppt
Hypertensive-Disorders-with-Pregnancy.ppthishamgamal8
 
PET,Prof S,Roshdy,9-9-2022.pdf
PET,Prof S,Roshdy,9-9-2022.pdfPET,Prof S,Roshdy,9-9-2022.pdf
PET,Prof S,Roshdy,9-9-2022.pdfSalahRoshdy2
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancymaliha shah
 
Hypertensive Disorders in Pregnancy, ( PIH)ppt
Hypertensive Disorders in Pregnancy, ( PIH)pptHypertensive Disorders in Pregnancy, ( PIH)ppt
Hypertensive Disorders in Pregnancy, ( PIH)pptBarikielMassamu
 
Hypertensive disease during px
Hypertensive disease during pxHypertensive disease during px
Hypertensive disease during pxMesfin Mulugeta
 
Gestetional hypertension, Preeclampsia and Eclampsia
Gestetional hypertension, Preeclampsia and EclampsiaGestetional hypertension, Preeclampsia and Eclampsia
Gestetional hypertension, Preeclampsia and Eclampsiasunil kumar daha
 
Path htn pregnancy
Path htn pregnancyPath htn pregnancy
Path htn pregnancyIdi Amadou
 
Hypertensive disorders of pregnancy_053935.ppt
Hypertensive disorders of pregnancy_053935.pptHypertensive disorders of pregnancy_053935.ppt
Hypertensive disorders of pregnancy_053935.pptKabir Ibrahim Jaen
 
Pregnancy Induced Hypertension.pptx
Pregnancy Induced Hypertension.pptxPregnancy Induced Hypertension.pptx
Pregnancy Induced Hypertension.pptxPrativa Kafle
 
PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...
PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...
PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...MohammadRaza607865
 
GESTATIONAL HYPERTENSIVE DISORDERS.pptx
GESTATIONAL HYPERTENSIVE DISORDERS.pptxGESTATIONAL HYPERTENSIVE DISORDERS.pptx
GESTATIONAL HYPERTENSIVE DISORDERS.pptxNIYONSENGAAntoine2
 
PIH-New_edited-13-09-10.ppt
PIH-New_edited-13-09-10.pptPIH-New_edited-13-09-10.ppt
PIH-New_edited-13-09-10.pptShama
 
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptxNATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptxokakadaniel
 
Management of Pre-eclampsia and eclampsia Case discussions
Management of Pre-eclampsiaand eclampsia Case discussionsManagement of Pre-eclampsiaand eclampsia Case discussions
Management of Pre-eclampsia and eclampsia Case discussionsMouafak Alhadithy
 

Similar to m1_f._kamwendo_-_hypertensive_disorders_in_pregnancy.ppt.pptx (20)

Hypertensive-Disorders-with-Pregnancy.ppt
Hypertensive-Disorders-with-Pregnancy.pptHypertensive-Disorders-with-Pregnancy.ppt
Hypertensive-Disorders-with-Pregnancy.ppt
 
PPH
PPHPPH
PPH
 
PET,Prof S,Roshdy,9-9-2022.pdf
PET,Prof S,Roshdy,9-9-2022.pdfPET,Prof S,Roshdy,9-9-2022.pdf
PET,Prof S,Roshdy,9-9-2022.pdf
 
Pih
PihPih
Pih
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
 
Hypertensive 181128174242
Hypertensive 181128174242Hypertensive 181128174242
Hypertensive 181128174242
 
Hypertensive Disorders in Pregnancy, ( PIH)ppt
Hypertensive Disorders in Pregnancy, ( PIH)pptHypertensive Disorders in Pregnancy, ( PIH)ppt
Hypertensive Disorders in Pregnancy, ( PIH)ppt
 
Hypertensive disease during px
Hypertensive disease during pxHypertensive disease during px
Hypertensive disease during px
 
Gestetional hypertension, Preeclampsia and Eclampsia
Gestetional hypertension, Preeclampsia and EclampsiaGestetional hypertension, Preeclampsia and Eclampsia
Gestetional hypertension, Preeclampsia and Eclampsia
 
Hypertensive in pregnancy
Hypertensive in pregnancyHypertensive in pregnancy
Hypertensive in pregnancy
 
HTN in Pregnancy.pptx
HTN in Pregnancy.pptxHTN in Pregnancy.pptx
HTN in Pregnancy.pptx
 
Path htn pregnancy
Path htn pregnancyPath htn pregnancy
Path htn pregnancy
 
PRE ECLAMPSIA .pptx
PRE ECLAMPSIA .pptxPRE ECLAMPSIA .pptx
PRE ECLAMPSIA .pptx
 
Hypertensive disorders of pregnancy_053935.ppt
Hypertensive disorders of pregnancy_053935.pptHypertensive disorders of pregnancy_053935.ppt
Hypertensive disorders of pregnancy_053935.ppt
 
Pregnancy Induced Hypertension.pptx
Pregnancy Induced Hypertension.pptxPregnancy Induced Hypertension.pptx
Pregnancy Induced Hypertension.pptx
 
PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...
PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...
PRE ECLAMPSIA Presentation in Clincial Pathological Conference in Hyderabad L...
 
GESTATIONAL HYPERTENSIVE DISORDERS.pptx
GESTATIONAL HYPERTENSIVE DISORDERS.pptxGESTATIONAL HYPERTENSIVE DISORDERS.pptx
GESTATIONAL HYPERTENSIVE DISORDERS.pptx
 
PIH-New_edited-13-09-10.ppt
PIH-New_edited-13-09-10.pptPIH-New_edited-13-09-10.ppt
PIH-New_edited-13-09-10.ppt
 
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptxNATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
NATIONAL PREECLAMPSIA PRESENTATION_2KNRH.pptx
 
Management of Pre-eclampsia and eclampsia Case discussions
Management of Pre-eclampsiaand eclampsia Case discussionsManagement of Pre-eclampsiaand eclampsia Case discussions
Management of Pre-eclampsia and eclampsia Case discussions
 

More from Ogunsina1

Lecture note session13-fp-and-hiv-supplemental.pptx
Lecture note session13-fp-and-hiv-supplemental.pptxLecture note session13-fp-and-hiv-supplemental.pptx
Lecture note session13-fp-and-hiv-supplemental.pptxOgunsina1
 
Contraception-counselling-and-provision-Chandra-Mouli-2019.pptx
Contraception-counselling-and-provision-Chandra-Mouli-2019.pptxContraception-counselling-and-provision-Chandra-Mouli-2019.pptx
Contraception-counselling-and-provision-Chandra-Mouli-2019.pptxOgunsina1
 
seminar on prostate cancer and awareness.ppt
seminar on prostate cancer and awareness.pptseminar on prostate cancer and awareness.ppt
seminar on prostate cancer and awareness.pptOgunsina1
 
Management of Diarrhea in Pediatrics[1].pdf
Management of Diarrhea in Pediatrics[1].pdfManagement of Diarrhea in Pediatrics[1].pdf
Management of Diarrhea in Pediatrics[1].pdfOgunsina1
 
pharmacology of Drug of Choice for pharmacist .pdf
pharmacology of Drug of Choice for pharmacist  .pdfpharmacology of Drug of Choice for pharmacist  .pdf
pharmacology of Drug of Choice for pharmacist .pdfOgunsina1
 
LECTURE NOTE ON Antihypertensives DRUGpdf
LECTURE NOTE ON  Antihypertensives DRUGpdfLECTURE NOTE ON  Antihypertensives DRUGpdf
LECTURE NOTE ON Antihypertensives DRUGpdfOgunsina1
 
LECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdf
LECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdfLECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdf
LECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdfOgunsina1
 
sfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptx
sfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptxsfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptx
sfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptxOgunsina1
 
Lecture note on GlaucomaAwareness2014.ppt
Lecture note on GlaucomaAwareness2014.pptLecture note on GlaucomaAwareness2014.ppt
Lecture note on GlaucomaAwareness2014.pptOgunsina1
 
Medication Adherence Pharmacist-Ogunsina.pdf
Medication Adherence Pharmacist-Ogunsina.pdfMedication Adherence Pharmacist-Ogunsina.pdf
Medication Adherence Pharmacist-Ogunsina.pdfOgunsina1
 
introduction to medical enzymology class 2
introduction to medical enzymology class 2introduction to medical enzymology class 2
introduction to medical enzymology class 2Ogunsina1
 
pre_and_eclampsia.ppt
pre_and_eclampsia.pptpre_and_eclampsia.ppt
pre_and_eclampsia.pptOgunsina1
 
ACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.pptACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.pptOgunsina1
 
TBIhomeless_FINAL.ppt
TBIhomeless_FINAL.pptTBIhomeless_FINAL.ppt
TBIhomeless_FINAL.pptOgunsina1
 
fever-presentation.ppt
fever-presentation.pptfever-presentation.ppt
fever-presentation.pptOgunsina1
 
Dr Ogunsina Malaria Management.ppt
Dr Ogunsina Malaria Management.pptDr Ogunsina Malaria Management.ppt
Dr Ogunsina Malaria Management.pptOgunsina1
 
Cardiac Range.ppt
Cardiac Range.pptCardiac Range.ppt
Cardiac Range.pptOgunsina1
 
surgicalinfection-180604172906.pdf
surgicalinfection-180604172906.pdfsurgicalinfection-180604172906.pdf
surgicalinfection-180604172906.pdfOgunsina1
 
obstetricsandgynaecology-180419155144.pdf
obstetricsandgynaecology-180419155144.pdfobstetricsandgynaecology-180419155144.pdf
obstetricsandgynaecology-180419155144.pdfOgunsina1
 

More from Ogunsina1 (20)

Lecture note session13-fp-and-hiv-supplemental.pptx
Lecture note session13-fp-and-hiv-supplemental.pptxLecture note session13-fp-and-hiv-supplemental.pptx
Lecture note session13-fp-and-hiv-supplemental.pptx
 
Contraception-counselling-and-provision-Chandra-Mouli-2019.pptx
Contraception-counselling-and-provision-Chandra-Mouli-2019.pptxContraception-counselling-and-provision-Chandra-Mouli-2019.pptx
Contraception-counselling-and-provision-Chandra-Mouli-2019.pptx
 
seminar on prostate cancer and awareness.ppt
seminar on prostate cancer and awareness.pptseminar on prostate cancer and awareness.ppt
seminar on prostate cancer and awareness.ppt
 
Management of Diarrhea in Pediatrics[1].pdf
Management of Diarrhea in Pediatrics[1].pdfManagement of Diarrhea in Pediatrics[1].pdf
Management of Diarrhea in Pediatrics[1].pdf
 
pharmacology of Drug of Choice for pharmacist .pdf
pharmacology of Drug of Choice for pharmacist  .pdfpharmacology of Drug of Choice for pharmacist  .pdf
pharmacology of Drug of Choice for pharmacist .pdf
 
LECTURE NOTE ON Antihypertensives DRUGpdf
LECTURE NOTE ON  Antihypertensives DRUGpdfLECTURE NOTE ON  Antihypertensives DRUGpdf
LECTURE NOTE ON Antihypertensives DRUGpdf
 
LECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdf
LECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdfLECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdf
LECTURE NOTE ON NAEM LECTURER EPIDEMIOLOGY A.pdf
 
sfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptx
sfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptxsfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptx
sfCare-Learning-Series-Polypharmacy-Intro-for-Clinicians.pptx
 
Lecture note on GlaucomaAwareness2014.ppt
Lecture note on GlaucomaAwareness2014.pptLecture note on GlaucomaAwareness2014.ppt
Lecture note on GlaucomaAwareness2014.ppt
 
Medication Adherence Pharmacist-Ogunsina.pdf
Medication Adherence Pharmacist-Ogunsina.pdfMedication Adherence Pharmacist-Ogunsina.pdf
Medication Adherence Pharmacist-Ogunsina.pdf
 
introduction to medical enzymology class 2
introduction to medical enzymology class 2introduction to medical enzymology class 2
introduction to medical enzymology class 2
 
pre_and_eclampsia.ppt
pre_and_eclampsia.pptpre_and_eclampsia.ppt
pre_and_eclampsia.ppt
 
ACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.pptACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.ppt
 
TBIhomeless_FINAL.ppt
TBIhomeless_FINAL.pptTBIhomeless_FINAL.ppt
TBIhomeless_FINAL.ppt
 
allergy.ppt
allergy.pptallergy.ppt
allergy.ppt
 
fever-presentation.ppt
fever-presentation.pptfever-presentation.ppt
fever-presentation.ppt
 
Dr Ogunsina Malaria Management.ppt
Dr Ogunsina Malaria Management.pptDr Ogunsina Malaria Management.ppt
Dr Ogunsina Malaria Management.ppt
 
Cardiac Range.ppt
Cardiac Range.pptCardiac Range.ppt
Cardiac Range.ppt
 
surgicalinfection-180604172906.pdf
surgicalinfection-180604172906.pdfsurgicalinfection-180604172906.pdf
surgicalinfection-180604172906.pdf
 
obstetricsandgynaecology-180419155144.pdf
obstetricsandgynaecology-180419155144.pdfobstetricsandgynaecology-180419155144.pdf
obstetricsandgynaecology-180419155144.pdf
 

Recently uploaded

Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...marcuskenyatta275
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...janusa9823#S0007
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxDr. Sohan Biswas
 
Tips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in IndoreTips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in IndoreGokuldas Hospital
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...bkling
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingMedicoseAcademics
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...BabaJohn3
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor rawSherrylee83
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Health Kinesiology Natural Bioenergetics
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsYash Garg
 

Recently uploaded (20)

Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
Tips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in IndoreTips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in Indore
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
 
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 

m1_f._kamwendo_-_hypertensive_disorders_in_pregnancy.ppt.pptx

  • 1. Hypertensive Disorders in Pregnancy By Francis Kamwendo @ Nkhota-kota Adapted from Obstetrics Simplified by Diaa M. EI-Mowafi
  • 2. Classification 1. PRE-EXISTING (CHRONIC) HYPERTENSION 2. PRE-ECLAMPSIA 1. Differential Diagnosis 2. Complications 3. Treatment 4. ECLAMPSIA
  • 3. Pre-existing (chronic) hypertension: – Hypertension is present before pregnancy, detected in early pregnancy (before 20 weeks in absence of vesicular mole) and postpartum. – Examples: • essential hypertension, • secondary to chronic renal disorders e.g. pyelonephritis and renal artery stenosis, • coarctation of the aorta, systemic lupus erythematosus and pheochromocytoma.
  • 4. PRE-EXISTING (CHRONIC) HYPERTENSION Causes • Essential hypertension: of unknown aetiology. • Secondary to chronic renal disorder: e.g. – Glomerulonephritis. – Hydronephrosis. – Pyelonephritis. – Renal artery stenosis. • Secondary to cardiovascular disease: e.g. – Coarctation of the aorta. – Polyartheritis nodosa. – Systemic lupus erythematosus.
  • 5. PRE-EXISTING (CHRONIC) HYPERTENSION • Causes • Secondary to endocrine disorders: e.g. – Primary aldosteronism. – Phaeochromocytoma. – Adrenocortical tumours. – Diabetes mellitus.
  • 6. Effect of Pregnancy on Chronic Hypertension • Blood pressure falls by the second trimester in most of cases, but rises during the third trimester to a level some what above that in early pregnancy. • Deterioration of the underlying disease.
  • 7. Effect of Chronic Hypertension on Pregnancy Maternal: • superimposed pre- eclampsia/ eclampsia in 15- 20% of cases Foetal: – Intrauterine growth retardation. – Intrauterine foetal death.
  • 8. Treatment • General and medical treatment • As pre-eclampsia regarding the following: • Rest • Antihypertensives • Observation
  • 9. Pregnancy-induced hypertension (PIH): – Transient hypertension: • Late onset hypertension, without proteinuria or pathologic oedema – Pre-eclampsia: • Hypertension with proteinuria and / or oedema after 20 weeks of pregnancy, but may be earlier in vesicular mole. – Eclampsia: • Pre-eclampsia + convulsions.
  • 10. Superimposed pre-eclampsia or eclampsia: – Development of pre-eclampsia or eclampsia in pre-existing hypertension detected by a further increase of 30 mmHg or more in systolic blood pressure or 15 mmHg or more in diastolic blood pressure.
  • 11. PRE-ECLAMPSIA • Incidence: 5-10%. • Aetiology: Although eclampsia had been described since 200 years, no definite aetiology is found for PIH and it is still a disease of theories.
  • 12. Predisposing factors • Primigravidae more than multigravidae. • Pre-existing hypertension. • Previous pre-eclampsia. • Family history of pre-eclampsia. • Hyperplacentosis i.e. excessive chorionic tissue as in hydatidiform mole, multiple pregnancy, uncontrolled diabetes mellitus and foetal haemolytic diseases. • Obesity. •
  • 13. Theories • The uteroplacental bed • Immunological factor • Genetic factor • Renin- angiotensin system • Atrial natriuretic peptide (ANP) • Prostaglandins • Neutrophils
  • 14. Pathological Changes • Vasospasm • Coagulation status • Sodium and water retention
  • 16. Signs • Hypertension: • Proteinuria (albuminuria): • Oedema:
  • 17. Hypertension • Blood pressure of 140/90 mmHg or more or an increase of 30 mmHg in systolic and/or 15 mmHg in diastolic blood pressure over the pre- or early pregnancy level.
  • 18. How to measure the blood pressure in pregnancy 1 • The patient should rest for at least 30 min. after arriving to the clinic. • Remove any tight clothing from the right arm. • The patient lies comfortably on the left side that her back makes an angle of about 30o with the bed. The right arm is supported to be with the sphygmomanometer at the same level with the patient’s sternum i.e. her heart. Each cm above or below the level of the heart induces a difference of 0.7mmHg in blood pressure reading. She should lie undisturbed in this position for 2-3 min. before blood pressure is measured.
  • 19. How to measure the blood pressure in pregnancy 2 • The cuff should be applied to the right upper arm with the connecting tubes pointing downwards, the centre of the rubber bag in the cuff is directly over the brachial artery leaving ante-cubital fossa free. • Apply cuff firmly but not tightly around the arm. • Feel the brachial artery and apply the stethoscope directly over it without undue pressure. • Pump up cuff rapidly to 20-30 mmHg above the point at which the pulse sound disappears, and take blood pressure reading without delay.
  • 20. How to measure the blood pressure in pregnancy 3 • Let air out slowly so that mercury falls steadily by 2-3 mm/sec. • Blood pressure measurement phases (Korotkoff): – Korotkoff I¾ Appearance of the sound¾ systolic reading. – Korotkoff II¾ Accentuation of the sound. – Korotkoff III ¾ Sound becomes harsh. – Korotkoff IV¾ Sound becomes muffled¾ diastolic reading. – Korotkoff V¾ Disappearance of the sound. • Korotkoff I and IV is the reading for systolic and diastolic blood pressure respectively. If you wait the disappearance of the sound to take the diastolic reading (as in non- pregnant state) you may reach down to zero because of the hyperdynamic circulation during pregnancy.
  • 21. How to measure the blood pressure in pregnancy 4 • Use the right arm for measuring because it is more convenient to the physician, but if the reading is 10 mmHg or more higher in the left arm use it in the future readings. • The blood pressure should be measured in two occasions at least 6 hours apart.
  • 22. Proteinuria (albuminuria) • It is urinary protein greater than 0.3gm/L in 24 hours collection or greater than 1gm/L in two random samples obtained at least 6 hours apart. • It indicates glomerular damage and almost always occurs after hypertension. • Proteinuria is usually in the range of 1-3 gm daily, of which 50-60% is albumin but in severe cases it may exceed 15gm.
  • 23. Oedema • It is weight gain of more than 1 kg in any one week or 2.25 kg in any one month. • Clinical oedema is present in about two-thirds of patients with PIH. However, two-thirds of pregnant women with clinical oedema do not develop hypertension.
  • 24. Symptoms These are usually manifestations of severe pre-eclampsia. • Headache: usually frontal but may be occipital. It is due to cerebral oedema and hypertension. • Visual disturbances: blurring of vision, flashes of light or blindness. • Epigastric or right upper quadrant pain: due to enlargement and subcapsular hemorrhage of the liver. • Nausea and vomiting: due to congestion of gastric mucosa and/ or cerebral oedema. • Oliguria or anuria: due to kidney pathology.
  • 25. Investigations • Complete urine examination: for proteinuria, pus cells, RBCs, casts, specific gravity, culture and sensitivity. • Kidney function tests: serum uric acid > 6 mg % is abnormal during pregnancy. It is more specific for pre-eclampsia than creatinine. • Coagulation status: Platelet count, fibrinogen and FDP as DIC may develop. • Eye fundus examination. • Tests for foetal well being: as – ultrasound, – daily foetal movement count, – non-stress test, – oxytocin challenge test (if needed).
  • 26. N.B. • Imminent eclampsia: It is a state in which the patient is about to develop eclampsia. Usually there are: – blood pressure much higher than 160 /110 mmHg, – heavy proteinuria (+++or ++++), – hyperreflexia, – severe continuous headache, – blurring of vision, – epigastric pain. • Fulminating pre-eclampsia: a rapidly deteriorating pre- eclampsia to be imminent eclampsia
  • 27. Pre-eclampsia Pre-existing (chronic) Hypertension Parity usually primigravida usually multigravida. Past History of pre-eclampsia may be present of hypertension in between pregnancies. Hypertension after the 20th week of pregnancy (except in vesicular mole) and disappears within 6 weeks postpartum before pregnancy, during the first 20 weeks and persists after 6 weeks postpartum. Proteinuria If present, it develops after hypertension If present, it develops before hypertension due to underlying renal disease.
  • 28. Pre-eclampsia Pre-existing (chronic) Hypertension Hyperreflexia may be present. absent. Fundus Examination Normal or retinal vessels spasm, oedema, exudate and papilloedema (oedema of the optic disc). Sclerotic changes. Serum Uric Acid Its increase is not proportionate to serum creatinine Its increase is propotionate to serum creatinine
  • 29. Differential Diagnosis • Other causes of hypertension • Other Causes of proteinuria • Other causes of oedema
  • 30. Other Causes of proteinuria • Contamination of urine by vaginal discharge this is excluded by examination of a midstream sample after cleansing the introitus with sterile water or saline or by using a catheter. • Urinary infection: excluded by microscopic examination and culture of urine. • Congestive heart failure and severe anaemia due to hypoxia of the kidney. • Orthostatic proteinuria: Proteinuria is detected at the end of the day while it is absent in the morning. This is due to pressure of the lumbar spines on the left renal vein during standing
  • 31. Other causes of oedema • General causes: cardiac, hepatic, renal or nutritional oedema. • Local causes: as inflammatory or deep vein thrombosis (usually unilateral). • Pressure of the gravid uterus on the pelvic veins may produce ankle oedema.
  • 32. Complications Maternal: – Convulsions and coma (eclampsia). – Cerebral haemorrhage. – Renal failure. – Heart failure. – Liver failure. – Disseminated intravascular coagulation. – Abruptio placentae. – Residual chronic hypertension in about 1/3 of cases. – Recurrent pre-eclampsia in next pregnancies. Foetal: – Intrauterine growth retardation (IUGR). – Intrauterine foetal death. – Prematurity and its complications.
  • 34. Prophylactic • Proper antenatal care: – To detect the high risk patients who may develop PIH through the screening tests. – Early detection of cases who have already developed PIH and examine them more frequently. • Low dose aspirin: – It inhibits thromboxane production from the platelets and the AII binding sites on platelets. – A low dose (60 mg daily) selectively inhibits thromboxane due to higher concentration of such a low dose in the portal circulation than systemic affecting the platelets when they pass through the portal circulation. The Prostacyclin production from the systemic vessels will not be affected.
  • 35. Curative • Delivery of the foetus and placenta is the only real treatment of pre-eclampsia. As the conditions are not always suitable for this, the treatment aims to prevent or minimize the maternal and foetal complications (see before) till reasonable maturation of the foetus.
  • 36. General measures: Observation: Maternal: • blood pressure twice daily. • urine volume and proteinuria daily, • oedema daily, • body weight twice weekly, • fundus oculi once weekly, • blood picture including platelet count, liver and renal functions particularly serum uric acid on admission. Foetal: • daily foetal movement count, • serial sonography, • non-stress and stress test if needed.
  • 37. Medical treatment • Antihypertensives: – decrease the maternal cerebral and cardiovascular complications but do not affect the foetal outcome. – Alpha-methyl-dopa (Aldomet): • It reduces the central sympathetic drive. • Dose: 250-500 mg every 6-8 hours up to a maximum dose of 4 gm/day. Its effect appears after 48 hours. • A loading single dose of 2 gm may act within 1-2 hours. • Side effects: headache, athenia and nightmares. – Hydralazine (Apresoline): • It is a vasodilator, increases renal and uteroplacental blood flow. • Dose: 20 mg slowly IV initially followed by 5mg every 20 min. until diastolic blood pressure is 100-110 mmHg. This regimen is used for severe and acute hypertension. Oral hydralazine can be used in the chronic situation as a second line treatment in a dose of 25-75 mg/ 6 hours. • Side effects: tachycardia, headache, flushing, nausea and vomiting. – Calcium channel blockers (Nifedipine): • It is a vasodilator acting by blocking the Ca influx into smooth muscle cells. • It can be given sublingually (acts within 10 minutes) or orally (acts within 30 minutes) in a dose of 10- 20 mg 2-3 times daily. • The higher the starting blood pressure the greater is the hypotensive effect. • Side effects: headache and flushing.
  • 38. Obstetric measures • Timing of delivery • Method of delivery • Intrapartum care • Postpartum care
  • 39. Timing of delivery: Severe pre-eclampsia is usually treated conservatively till the end of the 36th week to ensure reasonable maturation of the foetus. Indications of termination before 36th week include: Foetal: deteriorating placental function as judged by: – intrauterine growth retardation, – oligohydramnios, – reduced foetal movements, – abnormal foetal heart patterns, or – failing biochemical results. Maternal: deteriorating maternal condition as judged by: – blood pressure is sustained or exceeds 180/110 mmHg, – urine proteinuria > 5 gm/24 hours, – oliguria, – evidence of DIC, or – imminent or already developed eclampsia.
  • 40. Method of delivery: – Vaginal delivery may be commenced in vertex presentation by: • amniotomy + oxytocin if the cervix is favourable. • prostaglandin vaginal tablet (PGE2) if the cervix is not favourable. – Caesarean section is indicated in: • Foetal distress. • Late deceleration occurs with oxytocin challenge test. • Failure of induction of labour. • Other indications as contracted pelvis, and malpresentations.
  • 41. Intrapartum care: – Close monitoring of the foetus is indicated. – Proper analgesia to the mother. – Anti-Hypertensives may be given if needed. – 2nd stage of labour may be shortened by forceps.
  • 42. Postpartum care: – Methergin (Ergometrine) is better avoided as it may increase the blood pressure. – Continue observation of the mother for 48 hours. – Anti- hypertensive drugs are continued in a decreasing dose for 48 hours.